Enliven Therapeutics, Inc. (ELVN)
46.97
+0.76
(+1.64%)
USD |
NASDAQ |
Oct 02, 16:00
46.97
0.00 (0.00%)
After-Hours: 20:00
Enliven Therapeutics EPS Diluted (Quarterly) : -0.4909 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4909 |
| March 31, 2026 | -0.3762 |
| December 31, 2025 | -0.4769 |
| September 30, 2025 | -0.3245 |
| June 30, 2025 | -0.4862 |
| March 31, 2025 | -0.5703 |
| December 31, 2024 | -0.4649 |
| September 30, 2024 | -0.4797 |
| June 30, 2024 | -0.415 |
| March 31, 2024 | -0.5408 |
| December 31, 2023 | -0.471 |
| September 30, 2023 | -0.5062 |
| June 30, 2023 | -0.4082 |
| March 31, 2023 | -0.7953 |
| Date | Value |
|---|---|
| December 31, 2022 | 4.897 |
| September 30, 2022 | -3.269 |
| June 30, 2022 | -2.864 |
| March 31, 2022 | -3.013 |
| December 31, 2021 | -2.179 |
| September 30, 2021 | -2.192 |
| June 30, 2021 | -2.972 |
| March 31, 2021 | -2.334 |
| December 31, 2020 | -2.625 |
| September 30, 2020 | -2.864 |
| June 30, 2020 | -2.374 |
| March 31, 2020 | -3.637 |
| December 31, 2019 | -1.678 |
| September 30, 2019 | -1.533 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Definium Therapeutics, Inc. | -1.436 |
| Cocrystal Pharma, Inc. | -0.2295 |
| CNBX Pharmaceuticals, Inc. | -0.0001 |
| Arvinas, Inc. | 2.578 |
| Fulcrum Therapeutics, Inc. | -0.3433 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -32.48M |
| Total Expenses (Quarterly) | 32.48M |
| Enterprise Value | 2.547B |
| Earnings Yield | -3.55% |
| Normalized Earnings Yield | -3.552 |